George Siber
Directeur Technique/Scientifique/R&D chez Clearpath Vaccines Co.
Profil
George R.
Siber currently works at Affinivax, Inc., as Director from 2014, International Vaccine Institute, as Trustee from 2013, and Clearpath Vaccines Co., as Chief Scientific Officer.
Dr. Siber also formerly worked at Genocea Biosciences, Inc., as Executive Chairman from 2007 to 2013, Selecta Biosciences, Inc., as Non-Executive Director, Elicio Therapeutics, Inc. (Old), as Director, MassBiologics, as Director, Wyeth LLC, as Chief Scientific Officer & Executive VP from 1996 to 2007, Crucell NV, as Member-Supervisory Board from 2010 to 2011, Dana-Farber Cancer Institute, Inc., as Associate Professor, Harvard Medical School, as Associate Professor, and Wyeth Vaccines Research, as Chief Scientific Officer & Executive VP.
Dr. Siber received his doctorate degree from McGill University and undergraduate degree from Bishop's University.
Postes actifs de George Siber
| Sociétés | Poste | Début |
|---|---|---|
International Vaccine Institute
 International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Directeur/Membre du Conseil | 18/11/2013 |
| Clearpath Vaccines Co. | Directeur Technique/Scientifique/R&D | - |
Affinivax, Inc.
 Affinivax, Inc. BiotechnologyHealth Technology Affinivax, Inc. operates as a biotechnology company which develops novel conjugation technology. The company is headquartered in North Cambridge, MA. | Directeur/Membre du Conseil | 01/06/2014 |
Anciens postes connus de George Siber
| Sociétés | Poste | Fin |
|---|---|---|
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Directeur/Membre du Conseil | 28/02/2011 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | 01/01/2007 |
| Wyeth Vaccines Research | Directeur Technique/Scientifique/R&D | - |
| Harvard Medical School | Corporate Officer/Principal | - |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Formation de George Siber
| McGill University | Doctorate Degree |
| Bishop's University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
Dana-Farber Cancer Institute, Inc.
 Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
International Vaccine Institute
International Vaccine Institute Miscellaneous Commercial ServicesCommercial Services The International Vaccine Institute develops and distributes vaccines. The non-profit company is based in Seoul, South Korea. Jerome H. Kim has been the CEO of the South Korean company since 2015. | Commercial Services |
MassBiologics
 MassBiologics BiotechnologyHealth Technology Part of University of Massachusetts, Inc., MassBiologics is a company that aims to improve public health by discovering and developing products. The company is based in Mattapan, MA. The company's focus is on creating products for smaller patient populations, uncertain markets, and developing nations with limited resources and unique needs. | Health Technology |
Affinivax, Inc.
Affinivax, Inc. BiotechnologyHealth Technology Affinivax, Inc. operates as a biotechnology company which develops novel conjugation technology. The company is headquartered in North Cambridge, MA. | Health Technology |
| Clearpath Vaccines Co. | |
| Wyeth Vaccines Research |
